{"id":242252,"date":"2026-09-11T08:52:48","date_gmt":"2026-09-11T03:22:48","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=242252"},"modified":"2026-09-11T08:52:48","modified_gmt":"2026-09-11T03:22:48","slug":"biotech-services-stock-rises-43-percent-in-6-months","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/biotech-services-stock-rises-43-percent-in-6-months\/","title":{"rendered":"This Biotech Services Stock Rises 43% in 6 Months: What Powered the Rally?"},"content":{"rendered":"

Anthem Biosciences CMP Rs 942.30 (10 Sep 2026). 6-month return 43.28%. 52W range Rs 579.15 to Rs 977.55. Market cap approx Rs 53,083 Cr. FY26 PAT Rs 592 Cr, up 31%.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Anthem Biosciences, a Bengaluru-based CRDMO, is the biotech services stock behind a 43.28% gain in six months. The share closed at Rs 942.30 on 10 September 2026 after a record Q4 FY26, a Rs 1,275 crore institutional block deal and net cash of about Rs 1,720 crore lifted sentiment. It now trades near 90 times earnings, slightly above the average analyst target.<\/p>\n<\/div>\n

This biotech services stock has turned Rs 1 lakh into roughly Rs 1.43 lakh in six months. One Bengaluru-based drug research and manufacturing partner delivered a 6-month return of 43.28% as of 10 September 2026, ranking 35th in a screen of 101 large-cap and mid-cap NSE shares.<\/p>\n

The company is Anthem Biosciences Ltd<\/a> (NSE: ANTHEM)<\/strong>, a contract research, development and manufacturing organisation (CRDMO) that works for global pharma and biotech innovators. The Anthem Biosciences share price closed at Rs 942.30 on 10 September 2026, giving it a market value of approximately Rs 53,083 crore. This biotech services stock listed in July 2025 at an IPO price of Rs 570 and now trades about 65% above that issue price.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n